PERRIGO Co plc

Pharmaceutical Preparations

PRGO Pharmaceuticals & Biotechnology People in Pharmaceuticals & Biotechnology SEC CIK 0001585364 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$1.90B
138,769,245 shares Covers every share class this company has on file.
Insiders on file
8
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$7.76M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
0.41%
insider-held value divided by market capitalisation

What PERRIGO Co plc reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$4.25B
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$1.43B
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
8,100
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at PERRIGO Co plc

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against PERRIGO Co plc.
Insider Reported role Shares Value Last action
Officers 2
Svend Andersen President 161,906 $2.42M S Open-market sale Aug 20, 2024 position reported
Eduardo Guarita Bezerra Eduardo Guarita Bezerra CFO 72,942 $1.09M F Shares withheld for taxes Jun 5, 2026 position reported
Officers who also sit on the board 2
Patrick Lockwood-Taylor CEO 102,135 $1.52M F Shares withheld for taxes Jun 5, 2026 position reported
Geoffrey M Parker Geoffrey M Parker CFO 72,166 $1.08M F Shares withheld for taxes Jun 12, 2026 position reported
Directors 4
Bradley A Alford Bradley A Alford Board Member 41,160 $614.1K F Shares withheld for taxes Jun 12, 2026 position reported
Donal O'Connor Donal O'Connor Board Member 31,835 $475.0K F Shares withheld for taxes May 14, 2026 position reported
Adriana Karaboutis Adriana Karaboutis Board Member 27,629 $412.2K F Shares withheld for taxes May 14, 2025 position reported
Jeffrey B. Kindler Board Member 10,559 $157.5K F Shares withheld for taxes May 14, 2025 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought PERRIGO Co plc (PRGO) shares worth $268,487 between Aug 8, 2025 and Aug 18, 2025

Cluster buying

3 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought PERRIGO Co plc (PRGO) shares worth $268,487 between Aug 8, 2025 and Aug 18, 2025
Date Insider Transaction Shares Price Value Filing
Aug 8, 2025 Patrick Lockwood-Taylor P Open-market purchase 346 held after: 85,758 $22.38 $7,743 SEC filing ↗
Aug 8, 2025 Patrick Lockwood-Taylor P Open-market purchase 4,060 held after: 85,412 $22.37 $90,822 SEC filing ↗
Aug 8, 2025 Patrick Lockwood-Taylor P Open-market purchase 54 held after: 85,812 $22.37 $1,208 SEC filing ↗
Aug 18, 2025 Geoffrey M Parker P Open-market purchase 4,375 held after: 9,875 $22.97 $100,494 SEC filing ↗
Aug 18, 2025 Eduardo Guarita Bezerra P Open-market purchase 3,000 held after: 48,949 $22.74 $68,220 SEC filing ↗

Total of the rows above: $268,487, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 80 rows we hold, 8 are open-market purchases (P) and 4 open-market sales (S) — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for PERRIGO Co plc, newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Jun 12, 2026 Geoffrey M Parker F Shares withheld for taxes 469 $10.99 $5.2K SEC filing ↗
Jun 12, 2026 Geoffrey M Parker M Option exercise or conversion 976 $10.99 $10.7K SEC filing ↗
Jun 12, 2026 Bradley A Alford F Shares withheld for taxes 469 $10.99 $5.2K SEC filing ↗
Jun 12, 2026 Bradley A Alford M Option exercise or conversion 976 $10.99 $10.7K SEC filing ↗
Jun 5, 2026 Patrick Lockwood-Taylor F Shares withheld for taxes 12,906 $10.83 $139.8K SEC filing ↗
Jun 5, 2026 Patrick Lockwood-Taylor M Option exercise or conversion 25,230 $10.83 $273.2K SEC filing ↗
Jun 5, 2026 Eduardo Guarita Bezerra F Shares withheld for taxes 2,235 $10.83 $24.2K SEC filing ↗
Jun 5, 2026 Eduardo Guarita Bezerra M Option exercise or conversion 9,175 $10.83 $99.4K SEC filing ↗
May 15, 2026 Bradley A Alford F Shares withheld for taxes 3,507 $10.84 $38.0K SEC filing ↗
May 14, 2026 Donal O'Connor F Shares withheld for taxes 3,507 $10.84 $38.0K SEC filing ↗
May 14, 2026 Donal O'Connor M Option exercise or conversion 7,305 $10.84 $79.2K SEC filing ↗
May 14, 2026 Geoffrey M Parker F Shares withheld for taxes 3,507 $10.84 $38.0K SEC filing ↗
May 14, 2026 Geoffrey M Parker M Option exercise or conversion 7,305 $10.84 $79.2K SEC filing ↗
May 14, 2026 Bradley A Alford M Option exercise or conversion 7,305 $10.84 $79.2K SEC filing ↗
Apr 2, 2026 Patrick Lockwood-Taylor F Shares withheld for taxes 9,123 $10.85 $99.0K SEC filing ↗
Apr 2, 2026 Patrick Lockwood-Taylor M Option exercise or conversion 17,834 $10.85 $193.5K SEC filing ↗
Apr 2, 2026 Eduardo Guarita Bezerra F Shares withheld for taxes 1,551 $10.85 $16.8K SEC filing ↗
Apr 2, 2026 Eduardo Guarita Bezerra M Option exercise or conversion 6,369 $10.85 $69.1K SEC filing ↗
Mar 6, 2026 Patrick Lockwood-Taylor F Shares withheld for taxes 5,003 $10.72 $53.6K SEC filing ↗
Mar 6, 2026 Patrick Lockwood-Taylor M Option exercise or conversion 11,727 $10.72 $125.7K SEC filing ↗
Mar 6, 2026 Patrick Lockwood-Taylor F Shares withheld for taxes 4,240 $10.72 $45.5K SEC filing ↗
Mar 6, 2026 Patrick Lockwood-Taylor A Grant or award 13,839 $10.72 $148.4K SEC filing ↗
Mar 6, 2026 Eduardo Guarita Bezerra F Shares withheld for taxes 5,666 $10.72 $60.7K SEC filing ↗
Mar 6, 2026 Eduardo Guarita Bezerra A Grant or award 22,208 $10.72 $238.1K SEC filing ↗
Mar 6, 2026 Eduardo Guarita Bezerra F Shares withheld for taxes 1,213 $10.72 $13.0K SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Subsidiaries — 140 legal entities

Subsidiaries of PERRIGO Co plc

140 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.

This is not the full list. SEC rules only require a company to name its significant subsidiaries.

What that leaves out

Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.

Subsidiaries PERRIGO Co plc names in its most recent annual report, with the place each one is organised.
Subsidiary Organised in
Abtei Omega Pharma GmbH Germany
Aco Hud Nordic AB Sweden
Adriatic BST D.o.o. Podruznica Zagreb Croatia
Adriatic BST Trgovina in Storitve D.o.o. Slovenia
Adriatic Distribution doo Beograd Serbia
Athena Neurosciences, LLC Delaware
Chefaro Ireland Designated Activity Company Ireland
Cosmediet - Biotechnie SAS France
Despharma Kft. Hungary
Elan Europa Finance S.á r.l. Luxembourg
Elan International Services Limited Ireland
Elan Pharmaceuticals, LLC Delaware
Galpharm Healthcare Limited United Kingdom
Galpharm International Limited United Kingdom
HERA SAS France
HRA NewCo Luxembourg
HRA Pharma America, Inc. Delaware
HRA Pharma APAC J.V. Hong Kong
HRA Pharma Hong Kong Ltd. Hong Kong
HRA Pharma Switzerland SARL Switzerland
JLR Pharma S.A. Switzerland
Kazmira, LLC Colorado
L. Perrigo Company Michigan
Laboratoire de la Mer SAS France
Laboratoire HRA Pharma SAS France
Laboratoire Perrigo Pharma France SAS France
Medgenix Benelux NV Belgium
Monksland Holdings B.V. Netherlands
Naturwohl Pharma GmbH Germany
Oce Bio BV Belgium
Oce-Bio Nederland B.V. Netherlands
Omega Alpharm Cyprus Ltd. Cyprus
Omega Pharma AS Czech Republic
Omega Pharma Baltics SIA Latvia
Omega Pharma GmbH Austria
Omega Pharma Hungary Kft. Hungary
Omega Pharma Innovation & Development NV Belgium
Omega Pharma International NV Belgium
Omega Pharma Limited United Kingdom
Omega Pharma Manufacturing GmbH & Co. KG Germany
Omega Pharma Manufacturing Verwaltungs GmbH Germany
Omega Pharma Nederland B.V. Netherlands
Omega Pharma s.r.o. Slovakia
Omega Pharma Trading NV Belgium
Omega Teknika Designated Activity Company Ireland
P-Direct NL B.V. Netherlands
P. Services International ap z.o.o Poland
PBM Canada Holdings, LLC Delaware
PBM Holdings, LLC Delaware
PBM International Holdings, LLC Delaware
PBM Mexico Holdings, LLC Delaware
PBM Mexico Management, LLC Delaware
PBM Nutritionals, LLC Delaware
PBM Products Mexico S de R.L. de C.V. Mexico
PBM Products, LLC Delaware
Perrigo Americas Holdings, Inc. Michigan
Perrigo Asia Holding Company Ltd. Mauritius
Perrigo Australia PTY Limited Australia
Perrigo Belgium NV Belgium
Perrigo Bulgaria OOD Bulgaria
Perrigo Canada Company, Inc. Canada
Perrigo Capital NV Belgium
Perrigo China Business Trust China
Perrigo China Business Trustee, LLC Delaware
Perrigo Company Michigan
Perrigo Company of Tennessee, Inc. Tennessee
Perrigo Company plc Ireland
Perrigo Corporation Designated Activity Company Ireland
Perrigo Danmark A/S Denmark
Perrigo Deutschland GmbH Germany
Perrigo Diabetes Care, LLC Delaware
Perrigo Direct, Inc. Georgia
Perrigo España SA Spain
Perrigo Europe Invest NV Belgium
Perrigo Finance (US), LLC Michigan
Perrigo Finance Unlimited Company Ireland
Perrigo Florida, Inc. Florida
Perrigo France Deux SAS France
Perrigo France SAS France
Perrigo Hellas A.E. Greece
Perrigo Holding NV Belgium
Perrigo Holdings Unlimited Company Ireland
Perrigo International Finance Designated Activity Company Ireland
Perrigo International Holdings, LLC Michigan
Perrigo International Insurance Limited Bermuda
Perrigo International, LLC Michigan
Perrigo Investments, LLC Delaware
Perrigo IoM Holdings Limited Isle of Man
Perrigo Ireland 1 Designated Activity Company Ireland
Perrigo Ireland 10 Unlimited Company Ireland
Perrigo Ireland 13 Designated Activity Company Ireland
Perrigo Ireland 2 Designated Activity Company Ireland
Perrigo Ireland 4 Unlimited Company Ireland
Perrigo Israel Opportunities II Ltd. Israel
Perrigo Israel Trading Limited Partnership Israel
Perrigo Italia S.r.l Italy
Perrigo Kişisel Bakım Ürünleri Sanayi ve Ticaret Limited Şirketi Turkey
Perrigo Laboratories India LLP India
Perrigo Malta International Limited Malta
Perrigo Malta International Ltd. - US Branch —
Perrigo Management Company Michigan
Perrigo Mexico Investment Holdings, LLC Delaware
Perrigo Netherlands B.V. Netherlands
Perrigo New York, Inc. Delaware
Perrigo Norge AS Norway
Perrigo Österreich GmbH Austria
Perrigo Pharma Holding Nederland BV Netherlands
Perrigo Pharma International Designated Activity Company Ireland
Perrigo Pharma International Designated Activity Company Succursal Em Portugal Portugal
Perrigo Pharma Limited United Kingdom
Perrigo Poland Sp z.o.o Poland
Perrigo Portugal LDA Portugal
Perrigo Research & Development Company Michigan
Perrigo România S.R.L. Romania
Perrigo Sales Corporation Michigan
Perrigo Schweiz AG fka Interdelta S.A. Switzerland
Perrigo Science One Designated Activity Company Ireland
Perrigo Suomi Oy Finland
Perrigo Supply Chain International Designated Activity Company Ireland
Perrigo Sverige AB Sweden
Perrigo Trading (Shanghai) Co., Ltd. China
Perrigo UK Acquisition Limited United Kingdom
Perrigo Ukraine, LLC Ukraine
Perrigo Ventures Limited Partnership United Kingdom
Perrigo Wisconsin, LLC Delaware
Perrigo, LLC Delaware
PMI Branded Pharmaceuticals, Inc. Michigan
Ranir (Holdings) Limited United Kingdom
Ranir Changshu Oral Care CO., Ltd. China
Ranir Global Holdings, LLC Delaware
Ranir Limited United Kingdom
Ranir Shenzhen China
Ranir, LLC Delaware
Samenwerkende Apothekers Nederland B.V. Netherlands
SelfCare Holdings, LLC Delaware
Solent Dental Company Limited Hong Kong
Solent Oral Care Limited United Kingdom
Totalcare International Corp British Virgin Islands
Wrafton Laboratories Limited United Kingdom
Zibo Xinhua - Perrigo Pharmaceutical Company Ltd. China
What counts as a subsidiary

A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from PERRIGO Co plc’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from PERRIGO Co plc’s own SEC filings multiplied by the closing price we hold for the same stock.

Logo: Perrigo Company plc / Public domain , via Wikimedia Commons ↗ — used here to identify the company. Trademarks remain the property of their owner.